BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for ...
POMPANO BEACH, Fla., Oct. 31, 2025 (GLOBE NEWSWIRE) -- (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of ...
As of Friday, November 07, Organogenesis Holdings Inc.’s ORGO share price has surged by 41.26%, which has investors questioning if this is right time to sell.
BioStem Technologies, Inc. ("BioStem" or the "Company") (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization ...
ROSWELL, Ga., Oct. 31, 2025 /PRNewswire/ — StimLabs, a leading regenerative science company, announces the publication of its multicenter, retrospective study evaluating the real-world use of Relese, ...
A range of local health care programs is working to improve outcomes for mothers and infants, from complex in utero surgical procedures to supporting mothers who are grappling with substance abuse and ...
The product retains all three amnion, intermediate and chorion placental membrane layers, along with essential structural ...
Detailed price information for Mimedx Group Inc (MDXG-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback